Novo Nordisk and Eli Lilly Weight Loss Drug Stocks Slump Below Key Levels
Macro·2 articles across 2 outlets
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Novo Nordisk and Eli Lilly, the firms behind Ozempic, Wegovy and Zepbound, faced selling pressure on Friday.
The post Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said. appeared first on Investor's Business Daily.
Novo NordiskEli Lilly
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Novo Nordisk and Eli Lilly, the firms behind Ozemic, Wegovy and Zepbound, faced selling pressure on Friday.”
IBD — Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said.“Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.”
Yahoo Finance — Weight Loss Drug Stocks Slump. What Ozempic Maker Novo Nordisk Said.